Suchergebnisse - "Yedilbayev, Askar"

PubPharm (26)

1

Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024

von Otto-Knapp, R. | Edwards, S. | Kuchukhidze, G. | +4

2

PASS to End TB in Europe : Accelerated efforts on prevention and systematic screening to end tuberculosis in the WHO European Region by 2030

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Dadu, A. | Yedilbayev, A. | Migliori, G. | +5

3

Screening for tuberculosis among migrants in Europe : harmonising approaches during a humanitarian crisis?

enthalten in: The European respiratory journal | 2023

von den Boon, S. | Yedilbayev, A.

CommentOn: Eur Respir J. 2023 Oct 12;62(4):. - PMID 37230498

4

National policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for refugees and migrants among Member States of the WHO European Region

enthalten in: Journal of travel medicine | 2023

von Baggaley, R. | Nazareth, J. | Divall, P. | +14

5

Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region : Action is Needed by all Member States

enthalten in: The Journal of molecular diagnostics : JMD | 2022

von Maurer, F. | Shubladze, N. | Kalmambetova, G. | +23

6

Corrigendum to 'Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis' International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Maretbayeva, S. | Rakisheva, A. | Adenov, M. | +8

ErratumFor: Int J Infect Dis. 2021 Dec;113 Suppl 1:S91-S95. - PMID 33823277

7

Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally

enthalten in: The European respiratory journal | 2022

von Masini, T. | Kanchar, A. | Mirzayev, F. | +4

CommentOn: Eur Respir J. 2022 May 19;59(5):. - PMID 35589114

8

Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2022

von Simões, D. | Ehsani, S. | Stanojevic, M. | +14

9

Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for COVID-19 in Belarus : Mixed-Methods Study

enthalten in: International journal of environmental research and public health | 2022

von Sereda, Y. | Korotych, O. | Klimuk, D. | +7

10

Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Maretbayeva, S. | Rakisheva, A. | Adenov, M. | +8

ErratumIn: Int J Infect Dis. 2022 Aug;121:105. - PMID 35613479